-
1
-
-
34047201878
-
In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients
-
Frischmann ME, Kronenberg F, Trenkwalder E et al. In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients. Kidney International 2007; 71: 1036-1043.
-
(2007)
Kidney International
, vol.71
, pp. 1036-1043
-
-
Frischmann, M.E.1
Kronenberg, F.2
Trenkwalder, E.3
-
2
-
-
0031867582
-
Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function
-
Kostner KM, Clodi M, Bodlaj G et al. Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function. Eur J Clin Invest 1998; 28: 447-452.
-
(1998)
Eur J Clin Invest
, vol.28
, pp. 447-452
-
-
Kostner, K.M.1
Clodi, M.2
Bodlaj, G.3
-
3
-
-
0033980288
-
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure
-
Kronenberg F, Kuen E, Ritz E et al. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol 2000; 11: 105-115.
-
(2000)
J Am Soc Nephrol
, vol.11
, pp. 105-115
-
-
Kronenberg, F.1
Kuen, E.2
Ritz, E.3
-
4
-
-
0028168224
-
Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation
-
Kronenberg F, Konig P, Lhotta K et al. Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation. Arterioscler Thromb 1994; 14: 1399-1404.
-
(1994)
Arterioscler Thromb
, vol.14
, pp. 1399-1404
-
-
Kronenberg, F.1
Konig, P.2
Lhotta, K.3
-
5
-
-
15644361814
-
Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation
-
Kronenberg F, Trenkwalder E, Lingenhel A et al. Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation. J Lipid Res 1997; 38: 1755-1763.
-
(1997)
J Lipid Res
, vol.38
, pp. 1755-1763
-
-
Kronenberg, F.1
Trenkwalder, E.2
Lingenhel, A.3
-
6
-
-
0034877816
-
Renal handling of human apolipoprotein(a) and its fragments in the rat
-
Reblin T, Donarski N, Fineder L et al. Renal handling of human apolipoprotein(a) and its fragments in the rat. Am J Kidney Dis 2001; 38: 619-630.
-
(2001)
Am J Kidney Dis
, vol.38
, pp. 619-630
-
-
Reblin, T.1
Donarski, N.2
Fineder, L.3
-
7
-
-
30844470427
-
Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]
-
Cain WJ, Millar JS, Himebauch AS et al. Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a]. J Lipid Res 2005; 46: 2681-2691.
-
(2005)
J Lipid Res
, vol.46
, pp. 2681-2691
-
-
Cain, W.J.1
Millar, J.S.2
Himebauch, A.S.3
-
8
-
-
0024290239
-
Tissue distribution of [3H]cholesteryl linoleyl ether-labeled human Lp(a) in different rat organs
-
Ye SQ, Keeling J, Stein O et al. Tissue distribution of [3H]cholesteryl linoleyl ether-labeled human Lp(a) in different rat organs. Biochim Biophys Acta 1988; 963: 534-540.
-
(1988)
Biochim Biophys Acta
, vol.963
, pp. 534-540
-
-
Ye, S.Q.1
Keeling, J.2
Stein, O.3
-
9
-
-
0030666519
-
The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor
-
Argraves KM, Kozarsky KF, Fallon JT et al. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J Clin Invest 1997; 100: 2170-2181.
-
(1997)
J Clin Invest
, vol.100
, pp. 2170-2181
-
-
Argraves, K.M.1
Kozarsky, K.F.2
Fallon, J.T.3
-
10
-
-
0032975165
-
Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro
-
Niemeier A, Willnow T, Dieplinger H et al. Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro. Arterioscler Thromb Vasc Biol 1999; 19: 552-561.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 552-561
-
-
Niemeier, A.1
Willnow, T.2
Dieplinger, H.3
|